Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
OPERATING ACTIVITIES
Net income	$ 121	$ 12	$ 434	$ 501
Loss from discontinued operations, net of tax	0	0	0	(2)
Net income from continuing operations	121	12	434	503
Adjustments to determine net cash provided by operating activities:
Depreciation and amortization	139	133	406	405
Gain on unrealized derivatives and other realized derivatives in investing activities, net			(34)	(19)
Loss on sale or disposal of assets, net	4	0	4	1
Restructuring and impairment expenses, net			24	5
Loss on extinguishment of debt, net	0	0	5	0
Deferred income taxes, net			12	(7)
Equity in net loss (income) of non-consolidated affiliates	6	(6)	(1)	(14)
Loss (gain) on foreign exchange remeasurement of debt			14	(8)
Amortization of debt issuance costs and carrying value adjustments			8	12
Other, net			3	0
Changes in assets and liabilities including assets and liabilities held for sale (net of effects from divestitures):
Accounts receivable			(183)	669
Inventories			61	(96)
Accounts payable			(355)	(1,061)
Other assets			43	(4)
Other liabilities			(21)	(65)
Net cash provided by operating activities – continuing operations			420	321
Net cash used in operating activities – discontinued operations			0	(12)
Net cash provided by operating activities			420	309
INVESTING ACTIVITIES
Capital expenditures	(342)	(178)	(960)	(462)
Acquisition of business and other investments, net of cash acquired			0	(4)
Proceeds from sales of assets, third party, net of transaction fees and hedging			0	2
Proceeds from the sale of a business			2	3
Proceeds (outflows) from investment in and advances to non-consolidated affiliates, net			3	(37)
Proceeds from the settlement of derivative instruments, net			9	5
Other			11	15
Net cash used in investing activities			(935)	(478)
FINANCING ACTIVITIES
Proceeds from issuance of long-term and short-term borrowings			699	0
Principal payments of long-term and short-term borrowings			(604)	(380)
Revolving credit facilities and other, net			(281)	749
Debt issuance costs			(3)	(6)
Return of capital to our common shareholder			0	(100)
Net cash (used in) provided by financing activities			(189)	263
Net (decrease) increase in cash, cash equivalents and restricted cash			(704)	94
Effect of exchange rate changes on cash			(6)	(39)
Cash, cash equivalents and restricted cash – beginning of period			1,511	1,084
Cash, cash equivalents and restricted cash – end of period	801	1,139	801	1,139
Cash and cash equivalents	787	1,126	787	1,126
Restricted cash (included in other long-term assets)	14	13	14	13
Cash, cash equivalents and restricted cash – end of period	$ 801	$ 1,139	801	1,139
Supplemental Disclosures:
Accrued capital expenditures as of December 31			176	125
Leased assets obtained in exchange for new operating lease liabilities			$ 7	$ 27